If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

Share Price Information for Biome Tech (BIOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 76.00
Bid: 60.00
Ask: 75.00
Change: 6.00 (8.57%)
Spread: 15.00 (25.00%)
Open: 70.00
High: 76.00
Low: 67.50
Prev. Close: 70.00
BIOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Biome receives £282k grant

16 Nov 2022 07:00

RNS Number : 5289G
Biome Technologies PLC
16 November 2022
 

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

 

16 November 2022

 

Biome Technologies plc

 

("Biome", "the Company" or "the Group")

 

Biome receives £282k grant to scale-up novel biopolymers

 

Biome announces that its Bioplastics division (www.biomebioplastics.com) has been awarded £282,000 in funding from Innovate UK, the UK Government's innovation agency, to support the scale-up of novel compostable biopolymers for the flexible packaging and coatings industries in collaboration with Thomas Swan (www.thomas-swan.co.uk) and the University of Nottingham. The project has a total investment of £474,000 and is expected to last 18 months.

Over the last nine years, Biome has undertaken considerable research and development work on a range of biodegradable polymers, based on bio-based inputs. This work has involved seven universities and around 30 leading scientists and engineers. All the resultant polymers are subject to patent protection or patent application. Before this new Innovate UK grant, these novel polymers have only been scaled successfully from laboratory test-tube to small kilogram quantities on pilot plant equipment.

 

The new funding for this project will scale up one of these promising polymers to quantities of hundreds of kilograms on Thomas Swan's industrial-scale assets. This selected polymer is based on furan dicarboxylic acid (FDCA), an important new bio-based chemical. Such production will allow the performance and production process of this polymer to be evaluated at a commercially relevant scale.

 

Thomas Swan is a leading independent manufacturer of performance and fine chemicals with offices in the United States and China and a global network of distributors. The company manufactures over 100 products, from kilogram to multi-tonne quantities, and offers an experienced and flexible custom manufacturing service. Thomas Swan has collaborated with Biome's development for the last few years and is well-placed to support this specific project and ultimately manufacture Biome's novel FDCA based polymers at a commercial scale.

 

The University of Nottingham has worked with Biome for the past five years. Its contribution to this project will be led by Derek Irvine, Professor of Materials Chemistry at the institution's Faculty of Engineering. His team will support the technology transfer from the laboratory to Thomas Swan and work on further enhancements to the FDCA-derived polymer.

 

This work forms part of Biome's approach to providing highly functional added-value products to the market. It is envisaged that products derived from this collaboration will be commercialised after project completion.

 

Paul Mines, Biome Technologies' Chief Executive, commented:

 

"After nine years of significant work by Biome's scientists, engineers and supporting partners, it is great to be taking a substantial step towards industrialisation in bringing these FDCA-based polymers to the market. Thomas Swan and the University of Nottingham are great partners to support us on our journey to commercialise this new generation of bio-based and compostable polymers."

 

Harry Swan, Thomas Swan's Chief Executive and Owner, added:

 

"This is an excellent project that will see the acceleration of an important new sustainable product for Biome. It also sits well with Thomas Swan's own mission to inspire and deliver sustainable chemistry. Innovate UK grants are not easy to secure which lends great credibility to the technology and its potential. I look forward to seeing this exciting project progress with our partners, Biome and the University of Nottingham."

 

-Ends-

 

 

For further information please contact: Biome Technologies plc

 

Paul Mines, Chief Executive Officer

Rob Smith, Chief Financial Officer

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Sales and Corporate Broking)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

The Group comprises two divisions, Biome Bioplastics Limited ("Bioplastic") and Stanelco RF Technologies Limited ("RF Technologies").

Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil- based polymers.

Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

www.biometechnologiesplc.com www.biomebioplastics.com and www.thinkbioplastic.com www.stanelcorftechnologies.com

 

About Thomas Swan

Thomas Swan & Co. Ltd. is an independent chemical manufacturing company. With offices and warehousing in the UK, USA and China and a global network of distributors, they service the domestic and international markets and export to over 80 countries worldwide.

Founded in 1926 in Consett, in the North East of England - still home to their manufacturing facilities - Thomas Swan today produces over 100 products, in kilogramme to multi-tonne quantities, and offers an experienced and flexible manufacturing service.

www.thomas-swan.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFELLFLFLZFBQ
Date   Source Headline
28th Feb 201112:22 pmRNSTotal Voting Rights
23rd Feb 20114:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20114:35 pmRNSPrice Monitoring Extension
17th Feb 20117:00 amRNSAppointment of Nominated Adviser & Joint Brokers
5th Nov 20107:00 amRNSTrading Update
14th Oct 20107:00 amRNSDirector/PDMR Shareholding
7th Oct 20107:00 amRNSDirectorate Change
5th Oct 20107:00 amRNSNotification of Awards under Public Equity Plan
17th Sep 20104:37 pmRNSPrice Monitoring Extension
27th Aug 20107:00 amRNSHalf Yearly Report
13th Jul 20107:55 amRNSFirst Day of Dealings on AIM
12th Jul 20107:00 amRNSChange of Name
1st Jul 201010:07 amRNSTotal Voting Rights
22nd Jun 20101:07 pmRNSResult of AGM
22nd Jun 20107:00 amRNSAnnual General Meeting & Trading Update
21st Jun 20104:41 pmRNSSch 1 update - Stanelco plc
21st Jun 20104:15 pmRNSDirector/PDMR Shareholding: Correction
15th Jun 20105:03 pmRNSDirector/PDMR Shareholding
14th Jun 201012:40 pmRNSSchedule 1 - Stanelco PLC
14th Jun 201012:31 pmRNSResult of Meeting
14th Jun 20107:00 amRNSResult of the Firm Placing, Placing and Open Offer
27th May 20104:15 pmRNSPublication of Prospectus
27th May 20107:00 amRNSFirm Placing and Placing and Open Offer
25th May 20104:40 pmRNSSecond Price Monitoring Extn
25th May 20104:35 pmRNSPrice Monitoring Extension
21st May 20104:40 pmRNSSecond Price Monitoring Extn
21st May 20104:35 pmRNSPrice Monitoring Extension
30th Apr 20104:40 pmRNSSecond Price Monitoring Extn
30th Apr 20104:35 pmRNSPrice Monitoring Extension
30th Apr 201010:36 amRNSAnnual Report and Accounts
29th Apr 20107:01 amRNSInterim Management Statement
29th Apr 20107:00 amRNSPreliminary Results
19th Apr 20107:00 amRNSUpdate re Novamont S.p.A infringement claims
16th Apr 20107:00 amRNSAnnual Information Update
17th Feb 20108:00 amRNSBiome Bioplastics new HT bioplastic
25th Jan 201010:30 amRNSStanelco re-brands bioplastics business
9th Dec 20098:00 amRNSOrders for Fibre Optics systems in Asia
3rd Dec 20097:00 amRNSStatement re share price movement
25th Nov 20094:40 pmRNSSecond Price Monitoring Extn
25th Nov 20094:35 pmRNSPrice Monitoring Extension
9th Nov 200910:06 amRNSHolding(s) in Company
6th Nov 20097:00 amRNSInterim Management Statement
21st Oct 20093:17 pmRNSHolding(s) in Company
20th Oct 20094:35 pmRNSPrice Monitoring Extension
8th Sep 20094:45 pmRNSHolding(s) in Company
4th Sep 20094:35 pmRNSPrice Monitoring Extension
3rd Sep 20094:40 pmRNSSecond Price Monitoring Extn
3rd Sep 20094:35 pmRNSPrice Monitoring Extension
28th Aug 20097:00 amRNSInterim Results
13th Aug 20094:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.